Take together with our previous studies, these data provide further evidence that the PGC-1α-Sirt3 pathway plays a critical role in regulating ApoE4-induced cerebral hypometabolism and it may provide a novel strategy for the treatment and prevention of AD. Here, PPARGC1A is linked to Alzheimer disease.